Monday, March 13rd 2017
Vaxinano has signed a new research contract with a second industrial partner, a world leader in the animal health industry
Vaxinano has today signed a new R & D contract with a world leader in the veterinary pharmaceutical industry to evaluate its technology in the field of animal health. "Vaxinano's progress reflects the relevance of its technology" said Vincent Lemonnier, CEO of Vaxinano. With two partners signing contracts in only a few months, "we see that our technology is of interest", he added. This second contract offers new opportunities for Vaxinano and its partners.